Jim Shannon
Shadow DUP Spokesperson (Health), Shadow DUP Spokesperson (Transport), Shadow DUP Spokesperson (Human Rights)
To ask the Secretary of State for Health what estimate he has made of the amount spent on research to develop drugs to treat cancer in children in the UK in each of the last five years.
Daniel Poulter
The Parliamentary Under-Secretary of State for Health
Estimated expenditure on paediatric cancer drug research and development by the Department's National Institute for Health Research (NIHR) through its infrastructure for experimental medicine is shown in the following table:
| £ million | |
| 2008-09 | 0.3 |
| 2009-10 | 0.3 |
| 2010-11 | 0.3 |
| 2011-12 | 0.5 |
| 2012-13 | 0.4 |
Total NIHR spend on this topic is higher than this because expenditure by the NIHR Clinical Research Network (CRN) on paediatric cancer drug trials cannot be disaggregated from total CRN expenditure.
The Department has made no estimate of paediatric cancer drug research and development by other United Kingdom funders including industry and medical research charities.
Does this answer the above question?
Yes0 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.